NEURAL NETWORK MODEL AS THE MULTIDISCIPLINARY TEAM MEMBER IN
CLINICAL DECISION SUPPORT TO AVOID
of preclinical and
clinical studies, the research work enabled to develop the
original solvent for poorly soluble
Shi, Y.,
Bikkuzin, T.,
Song, Z.,
Jin, X.,
Jin, H.,
Li, X.,
Zhang, H. (2017) the potential to be
clinically applied as a substitute
for human cornea in lamellar keratoplasty. Porcine
Afolabi, A.,
Hu, SN.,
Wang, C.,
Zhu, YC.,
Mustafina, I.,
Lin, L.,
Zheng, GH.,
Zhe, CY.,
Jia, HB.,
Hou, JB.,
Yu, B. (2017) burden in high-income countries. ACS refers to a constellation of
clinical symptoms that are compatible
Motloch, L.J.,
Larbig, R.,
Darabi, T.,
Reda, S.,
Motloch, K.A.,
Wernly, B.,
Lichtenauer, M.,
Gebing, T.,
Schwaiger, A.,
Zagidullin, N.,
Wolny, M.,
Hoppe, U.C. (2017) clinical symptoms. Hyperpolarization-activated cyclic nucleotide channel 4 (HCN4) underlies the pacemaker
blind randomized prospective one-center comparative placebo-controlled
clinical trial is carried out